rolipram has been researched along with Breast Neoplasms in 4 studies
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Resveratrol (RSVL) is a well-established chemopreventive agent in human breast cancer models." | 7.72 | Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. ( Alkhalaf, M; El-Mowafy, AM, 2003) |
| "Resveratrol (RSVL) is a well-established chemopreventive agent in human breast cancer models." | 3.72 | Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. ( Alkhalaf, M; El-Mowafy, AM, 2003) |
| "We demonstrate here using MDA-MB-435 breast carcinoma cells that alpha6beta4 stimulates chemotactic migration, a key component of invasion, but that it has no influence on haptotaxis." | 1.30 | Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells. ( Mercurio, AM; O'Connor, KL; Shaw, LM, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Germain, AR | 1 |
| Carmody, LC | 1 |
| Nag, PP | 1 |
| Morgan, B | 1 |
| Verplank, L | 1 |
| Fernandez, C | 1 |
| Donckele, E | 1 |
| Feng, Y | 1 |
| Perez, JR | 1 |
| Dandapani, S | 1 |
| Palmer, M | 1 |
| Lander, ES | 1 |
| Gupta, PB | 1 |
| Schreiber, SL | 1 |
| Munoz, B | 1 |
| Mukherjee, P | 1 |
| Bagchi, A | 1 |
| Banerjee, A | 1 |
| Roy, H | 1 |
| Bhattacharya, A | 1 |
| Biswas, A | 1 |
| Chatterji, U | 1 |
| El-Mowafy, AM | 1 |
| Alkhalaf, M | 1 |
| O'Connor, KL | 1 |
| Shaw, LM | 1 |
| Mercurio, AM | 1 |
4 other studies available for rolipram and Breast Neoplasms
| Article | Year |
|---|---|
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neopla | 2013 |
PDE4 inhibitor eliminates breast cancer stem cells via noncanonical activation of mTOR.
Topics: Breast Neoplasms; Female; Humans; Neoplastic Stem Cells; Paclitaxel; Phosphatidylinositol 3-Kinases; | 2022 |
Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Antineoplastic | 2003 |
Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Antibodies; Antigens, Surface; Bre | 1998 |